Abstract
It is currently accepted that a positive Western blot (WB) HIV antibody test is synonymous with HIV infection and the attendant risk of developing AIDS. In this communication we present a critical evaluation of the presently available data on HTV isolation and antibody testing. This evidence indicates that: (1) the antibody tests are not standardized; (2) the antibody tests are not reproducible; (3) the WB proteins (bands) which are considered to be encoded by the HTV genome and to be specific to HIV may not be encoded by the HIV genome and may in fact represent normal cellular proteins; (4) even if the proteins are specific to HIV, because no gold standard has been used to determine specificity, a positive WB may represent nothing more than cross-reactivity with non-HIV antibodies present in AIDS patients and those at risk. We conclude that the use of antibody tests as a diagnostic and epidemiological tool for HIV infection needs to be reappraised.
References
Ratner, L., Haseltine, W., Patarca, R.P. et al. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313: 277–284.
Hausmann, E.H.S., Gelderblom, H.R., Clapham, P.R. et al. 1987. Detection of HIV envelope specific antibodies by immunoelectron microscopy and correlation with antibody liter and virus neutralizing activity. J. Virol. Meth. 16: 125–137.
Pinter, A., Honnen, W.J., Tilley, S.A. et al. 1989. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63: 2674–2679.
Barré-Sinoussi, F., Chermann, J.C., Rey, F. et al. 1983. Isolation of a T-lymphotrophic retrovirus from a patient at risk for Acquired Immune Deficiency Syndrome (AIDS). Science 220: 868–871.
Schüpbach, J., Popovic, M., Gilden, R.V. et al. 1984. Serological analysis of a subgroup of human T-lymphotrophic retroviruses (HTLV-III) associated with AIDS. Science 224: 503–505.
Damsky, C.H., Sheffield, J.B., Tuszynski, G.P. et al. 1977. Is there a role for actin in virus budding? J. Cell. Biol. 75: 593–605.
Stanislawsky, L., Mongiat, F., Neto, V.M. et al. 1984. Presence of actin in oncornaviruses. Biochem. Biophys. Res. Com. 118: 580–586.
Papadopulos-Eleopulos, E., Turner, V.F. and Papadimitriou, J.M. 1992. Oxidative stress, HIV and AIDS. Res. Immunol. 143: 145–148.
Hinshaw, D.B., Burger, J.M., Beals, T.F. et al. 1991. Actin polymerization in cellular oxidant injury. Arch. Biochem. Biophys. 228: 311–316.
Bach, M.A., Lewis, D.E., McClure, J.E. et al. 1986. Monoclonal anti-actin antibody recognizes a surface molecule on normal and transformed human B lymphocytes: Expression varies with phase of cell cycle. Cell. Immunol. 98: 364–374.
Stricker, R.B., Abrams, D.I., Corash, L. et al. 1985. Target platelet antigen in homosexual men with immune thrombocytopenia. NEJM 313: 1375–1380.
Henderson, L.E., Sowder, R., Copeland, T.D. et al. 1987. Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Virol. 61: 629–632.
Wong-Staal, F. and Gallo, R.C. 1985. Human T-lymphotropic retroviruses. Nature 317: 395–403.
Genesca, J., Jett, B.W., Epstein, J.S. et al. 1989. What do Western blot indeterminate patterns for Human Immunodeficiency Virus mean in EIA-negative blood donors? Lancet II: 1023–1025.
Ranki, A., Johansson, E. and Krohn, K. 1988. Interpretation of antibodies reacting solely with human retroviral core proteins. NEJM 318: 448–449.
Delord, B., Ottmann, M., Schrive, M.H. et al. 1991. HIV-1 expression in 25 infected patients: A comparison of RNA PCR, p24 EIA in plasma and in situ hybridization in mononuclear cells, p. 113. In: Vol. I, Abstracts VII International Conference on AIDS, Florence, Italy.
Todak, G., Klein, E., Lange, M. et al. 1991. A clinical appraisal of the p24 antigen test, p. 326. In: Vol. I, Abstracts VII International Conference on AIDS, Florence, Italy.
Courouce, A., Muller, J. and Richard, B. 1986. False-positive Western blot reactions to human immunodeficiency virus in blood donors. Lancet II: 921–922.
Stricker, R.B., McHugh, T.M., Moody, D.J. et al. 1987. An AIDS-related Cytotoxic autoantibody reacts with a specific antigen on stimulated CD4 + T cells. Nature 327: 710–713.
Chassagne, J., Verelle, P., Fonck, Y. et al. 1986. Detection of the lymphadeno-pathy-associated virus p18 in cells of patients with lymphoid diseases using a monoclonal antibody. Ann. Inst. Pasteur/Immunol. 137D: 403–408.
Parravicini, C.L., Klatzmann, D., Jaffray, P. et al. 1988. Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues. AIDS 2: 171–177.
Matsiota, P., Chamaret, S., Montagnier, L. et al. 1987. Detection of natural autoantibodies in the serum of anti-HIV positive-individuals. Ann. Inst. Pasteur/Immunol. 138: 223–233.
Popovic, M., Sarngadharan, M.G., Read, E. et al. 1984. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–500.
Wilber, J.C. 1991. New developments in diagnosing infections, p. 1–15. In: AIDS Clinical Review, P. Volbering, M. A. Jacobson (Eds.). Marcel Dekker Inc., New York.
Lundberg, G.D. 1988. Serological diagnosis of human immunodeficiency virus infection by Western blot testing. JAMA 260: 674–679.
Zolla-Pazner, S., Gorny, M.K. and Honnen, W.J. 1989. Reinterpretation of human immunodeficiency virus Western blot patterns. NEJM 320: 1280–1281.
Burke, D.S. 1989. Laboratory diagnosis of human immunodeficiency virus infection. Clin. Lab. Med. 9: 369–392.
Maskill, W.J. and Gust, I.D. 1992. HIV-1 testing in Australia. Australian Prescriber 15: 11–13.
DeCock, K.M., Selik, R.M., Soro, B. et al. 1991. AIDS surveillance in Africa: A reappraisal of case definitions. BMJ 303: 1185–1189.
Voevodin, A. 1992. HIV screening in Russia. Lancet 339: 1548.
Working Group on AIDS Case Definition 1990. Epidemiol. Bull. 4: 9–11.
Edwards, V.M., Mosley, J.W. and the Transfusion Safety Study Group. 1991. Reproducibility in quality control of protein (Western) immunoblot assay for antibodies to human immunodeficiency virus. Am. J. Clin. Pathol. 91: 75–78.
CDC. 1989. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 Infections. MMWR 38 No. S-7: 1–7.
Weiss, S.H., Goedert, J.J., Sarngadharan, M.G. et al. 1985. Screening test for HTLV-III (AIDS agent) antibodies. JAMA 253: 221–225.
Weiss, R. and Thier, S.O. 1988. HIV testing is the answer—what's the question? NEJM 319: 1010–1012.
Burke, D.S., Brundage, J.F., Redfield, R.R. et al. 1988. Measurement of the false positive rate in a screening program for human immunodeficiency virus infections. NEJM 319: 961–964.
Scarlatti, G.S., Lombardi, V., Plebani, A. et al. 1991. Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children. AIDS 5: 1173–1178.
Griner, P.F., Mayewski, R.J., Mushlin, A.I. et al. 1981. Selection and interpretation of diagnostic tests and procedures. Ann. Int. Med. 94 (Part 2): 559–563.
CDC. 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. JAMA 258: 1143–1145.
Conley, C.L. and Savarese, D. 1989. Biologic false-positive serologic tests for syphilis and other serologic abnormalities in autoimmune hemolytic anemia and thromobocytopenic purpura. Medicine 68: 67–84.
Boue, F., Dreyfus, M., Bridley, F. et al. 1990. Lupus anticoagulant and HIV infection: A prospective study. AIDS 4: 467–471.
Jaffe, J.H., Moore, J.D., Cone, E.J. et al. 1986. HTLV-III seropositivity in 1971–1972 parenteral drug abusers—a case of false positives or evidence of viral exposure? NEJM 314: 1387–1388.
Biggar, R.J., Gigase, P.L., Melbye, M. et al. 1985. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet II: 520–523.
Ternynck, T. and Avrameas, S. 1986. Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities. Immunol. Rev. 94: 99–112.
Pateraki, E., Kaklamani, E., Portocalas, K.R. et al. 1986. Autoantibodies in systemic lupus erythematosus and normal subjects. Clin. Rheumatol. 5: 338–345.
Morton, D.L. and Malmgren, R.A. 1968. Human osteosarcomas: immunologic evidence suggesting an associated agent. Science 162: 1279–1281.
Hirshaut, Y., Pei, D.T., Marcove, R.C. et al. 1974. Seroepidemiology of human sarcoma antigen (S1). NEJM 291: 1103–1107.
Kurth, R., Teich, N.M., Weiss, R. et al. 1977. Natural human antibodies reactive with primate type-C viral antigens. Proc. Natl. Acad. Sci. 74: 1237–1241.
Snyder, H.W. and Fleissner, E. 1980. Specificity of human antibodies to oncovirus glycoproteins: Recognition of antigen by natural antibodies directed against carbohydrate structures. Proc. Natl. Acad. Sci. 77: 1622–1626.
Barbacid, M., Bolognesi, D. and Aaronson, S.A. 1980. Humans have antibodies capable of recognizing oncoviral glycoproteins: Demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc. Natl. Acad. Sci. 77: 1617–1621.
Essex, M., McLane, M.F., Lee, T.H. et al. 1983. Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science 220: 859–862.
Novick, D.M., Des Jarlais, D.C., Kreek, M.J. et al. 1988. Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease. Alcoholism Clin. Exp. Res. 12: 687–690.
European Collaborative Study. 1991. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 337: 253–260.
Beneviste, R.E., Ochs, H.D., Fischer, S.H. et al. 1986. Screening for antibodies to LAV/HTLV-III in recipients of immunoglobulin preparations. Lancet I: 1090–1092.
Burinsky, K.I., Chaplinskas, S.A., Syrtsev, V.A. et al. 1988. Reactivity to gag-and env-related sequences in immunoblot assay is not necessarily indicative of HIV infection. AIDS 2: 405–406.
Calabrese, L.H. 1988. Autoimmune manifestations of human immunodeficiency virus (HIV) infection. Clin. Lab. Med. 8: 269–279.
Bonara, P., Maggioni, L. and Colombo, G. 1991. Anti-lymphocyte antibodies and progression of disease in HIV infected patients, p. 149. In: Vol. II, VII International Conference on AIDS, Florence, Italy.
Tumietto, F., Costigliola, P., Ricchi, E. et al. 1991. Anti-lymphocyte autoantibodies: evaluation and correlation with different stages of HIV infection, p. 149. In: Vol. II, VII International Conference on AIDS, Florence, Italy.
Morozov, V.A., Ilyinskii, P.O., Uckert, W.A. et al. 1989. Antibodies to structural and nonstructural gag-coded proteins of type-D retroviruses in
Lucey, D.R., Hendrix, C.W., Andrzejewski, C. et al. 1992. Comparison by race of total serum IgG, IgA, and IgM with CD4 + T-cell counts in North American persons infected with the human immunodeficiency virus type 1. J. Acquir. Immun. Defic. Syndr. 5: 325–332.
Papadopulos-Eleopulos, E. 1988. Reappraisal of AIDS: Is the oxidation induced by the risk factors the primary cause? Med. Hypotheses 25: 151–162.
Papadopulos-Eleopulos, E., Turner, V.F. and Papadimitriou, J. 1992. Kaposi's sarcoma and HIV. Med. Hypotheses 39: 22–29.
Igel, H.J., Turner, H.C., Kotin, P. et al. 1969. Mouse leukaemia virus activation by chemical carcinogens. Science 166: 624–1626.
Sterk, C. 1988. Cocaine and HIV seropositivity. Lancet I: 1052–1053.
Kion, T.A. and Hoffmann, G.W. 1991. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 253: 1138–1140.
Conley, L.J. and Holmerg, S.D. 1992. Transmission of AIDS from blood screened negative for antibody to the human immunodeficiency virus. NEJM 326: 1499.
Burgher, H., Weiser, B., Robinson, W.S. et al. 1985. Transient antibody to lymphadenopathy-associated/human T-lymphotrophic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. Ann. Int. Med. 103: 545–547.
Esteva, M.H., Blasini, A.M., Ogly, D. and Rodriguez, M. A. 1992. False positive results from antibody to HIV in two men with systemic lupus erythre-matosus. Ann. Rhem. Dis. 51: 1071–1073.
Dummer, J.S., Erb, S., Breinig, M.K. et al. 1989. Infection with human immunodeficiency virus in the Pittsburgh transplant population. Transplantation 47: 134–139.
Pitchenik, A.E., Burr, J., Suarez, M. et al. 1987. Human T-cell lymphotrophic virus-Ill (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. Am. Rev. Respir. Dis. 135: 875–879.
Nzilambi, N., Mann, J.M., Francis, H. et al. 1986. Seroprevalence among tuberculosis patients in Zaire. In: Abstracts II International AIDS Conference, Paris, No.105:S17b.
St. Louis, M.E., Rauch, K.J., Peterson, L.R. et al. 1990. Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. NEJM 323: 213–218.
Chamberland, M., Conley, L. and Dondero, T. 1988. Epidemiology of hetero-sexually acquired AIDS—United States, p. 264. In: Abstacts IV International AIDS Conference, Stockholm.
New York City AIDS Surveillance Report, January-March 1992.
Rodriquez, L., Dewhurst, S., Sinangil, F. et al. 1985. Antibodies to HTLV-III/ LAV among aboriginal Amazonian Indians in Venezuela. Lancet II: 1098–1100.
Volsky, D.J., Wu, Y.T., Stevenson, M. et al. 1986. Antibodies to HTLV-III/ LAV in Venezuelan patients with acute malarial syndromes. NEJM 314: 647.
Rous, P. 1911. A Sarcoma of the fowl transmissible by an agent separable from the tumor cells. J. Exp. Med. 13: 397–411.
Toplin, I. 1973. Tumor virus purification using zonal rotors. Spectra No. 4: 225–235.
Temin, H.M. and Baltimore, D. 1972. RNA-directed DNA synthesis and RNA tumor viruses. Adv. Vir. Res. 17: 129–186.
RNA tumor viruses. 1982. Weiss, R., Teich, N., Varmus, J., Coffin, J. (Eds.). Cold Spring Harbor Laboratory. Cold Spring Harbor, New York.
Bader, J.P. 1975. Reproduction of RNA tumor viruses, p. 253–331. In: Comprehensive Virology Vol. 4. H. Fraenkel-Conrat, R.R. Wagner (Eds.). Plenum Press, New York.
Sinoussi, F., Mendiola, L., Chermann, J.C. et al. 1973. Purification and partial differentiation of the particles of murine sarcoma virus (M. MSV) according to their sedimentation rates in sucrose density gradients. Spectra No. 4: 237–243.
Amiesen, J.C. and Capron, A. 1991. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12: 102–105.
Wyllie, A.H., Kerr, J.F.R. and Currie, A.R. 1980. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68: 252–306.
Hoxie, J.A., Fitzharris, T.P., Youngbar, P.R. et al. 1987. Nonrandom association of cellular antigens with HTLV-III virions. Hum. Immunol. 18: 39–52.
McKeating, J.A. and Moore, J.P. 1991. HIV intectivity. Nature 349: 660.
Masquelier, B., Combeau, T. and Poveda, J. 1991. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovu-dine (ZDV). J. Acquir. Immun. Defic. Syndr. 4: 499–505.
Grunow, R., Valentin, A., Fenyo, E.M. et al. 1991. Release of HIV-1 core protein from infected cells independent of infectious virus particles, p. 157. In: Vol. I, Abstracts VII International Conference on AIDS, Florence, Italy.
Tedder, R.S., Semple, M.G., Tenant-Flowers, M. et al. 1992. HIV, AIDS, and zidovudine. Lancet 339: 805–806.
Lemaître, M., Guétard, D., Hénin, Y. et al. 1990. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. Res. Virol. 141: 5–16.
Boulerice, F., Bour, S., Geleziunas, R. et al. 1990. High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells. J. Virol. 64: 1745–1755.
Ehrnst, A., Sonnerborg, A., Bergdahl, S. and Strammegard, O. 1988. Efficient isolation of HIV from plasma during different stages of HIV infection. J. Med. Virol. 26: 23–32.
Learmont, J., Tindall, B., Evans, L. et al. 1992. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340: 863–867.
Popovic, M., Sarngadharan, M.G., Read, E. et al. 1984. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–500.
Gallo, R.C., Sarin, P.S. and Wu, A.M. 1973. On the nature of the nucleic acids and RNA dependent DNA polymerase from RNA tumor viruses and human cells, p. 13–34. In: Possible Episomes in Eukaryotes. L.G. Silvestri (Ed.). North-Holland Publishing Company, Amsterdam.
Whitkin, S.S., Higgins, P.J. and Bendich, A. 1978. Inhibition of reverse transcriptase and human sperm DNA polymerase by anti-sperm antibodies. Clin. Exp. Immunol. 33: 244–251.
Tomley, F.M., Armstrong, S.J., Mahy, B.W.J. and Owen, L.N. 1983. Reverse transcriptase activity and particles of retroviral density in cultured canine lymphosarcoma supernatants. Br. J. Cancer 47: 277–284.
Weissbach, A., Baltimore, D., Bollum, F. et al. 1975. Nomenclature of euka-ryotic DNA polymerases. Science 190: 401–402.
Gallo, R. ., Wong-Staal, F., Reitz, M. et al. 1976. Some evidence for infectious type-C virus in humans, p. 385–407. In: Animal Virology. D. Baltimore, A.S. Huang, C.F. Fox (Eds.). Academic Press Inc., New York.
Panem, S., Prochownik, E.V., Reale, F.R. et al. 1975. Isolation of type-C virions from a normal human fibroblast strain. Science 189: 297–299.
Panem, S., Prochownik, E.V., Knish, W.M. and Kirsten, W.H. 1977. Cell generation and type-C virus expression in the human embryonic cell strain HEL-12. J. Gen. Virol. 35: 487–495.
Panem, S. 1979. C-type virus expression in the placenta. Curr. Top. Pathol. 66: 175–189.
Sarngadharan, M.G., Robert-Guroff, M. and Gallo, R.C. 1978. DNA polymerases of normal and neoplastic mammalian cells. Biochim. Biophys. Acta. 516: 419–487.
Klatzmann, D., Barré-Sinoussi, P., Nugeyre, M. T. et al. 1984. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225: 59–63.
Montagnier, L. 1985. Lymphadenopathy-associated virus:From molecular biology to pathogenicity. Ann. Int. Med. 103: 689–693.
Gendelman, H.E., Orenstein, J.M., Martin, M.A. et al. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167: 1428–1441.
Gelderblom, H.R., Hausmann, E.H.S., Özel, M. et al. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virol. 156: 171–176.
Gelderblom, H., Reupke, H., Winkel, T. et al. 1987. MHC-antigens: Constituents of the envelopes of human and simian immunodeficiency viruses. Z. Naturforsch. 42C: 1328–1334.
Gelderblom, H.R., Reupke, H. and Pauli, G. 1985. Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? Lancet 11: 1016–1017.
Neidrig, M., Rabanus, J.P., L'Age Stehr, J. et al. 1988. Monoclonal antibodies directed against human immunodeficiency virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency virus. J. Gen. Virol. 69: 2109–2114.
Gelderblom, H.R., Özel, M., Hausmann, E.H.S. et al. 1988. Fine structure of human immunodeficiency virus (HIV), immunolocalization of structural proteins and virus-cell relation. Micron Microsc. 19: 41–60.
Meerloo, T., Parmentier, H.K., Osterhaus, A. et al. 1992. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. AIDS 6: 1105–1116.
Lecatsas, G. and Taylor, M.B. 1986. Pleomorphism in HTLV-III, the AIDS virus. S. Afr. Med. J. 69: 793–794.
Hockley, D.J., Wood, R.D., Jacobs, J.P. et al. 1988. Electron microscopy of human immunodeficiency virus. J. Gen. Virol. 69: 2455–2469.
Dourmashkin, R.R., O'Toole, C.M., Bucher, D. and Oxford, J.S. 1991. The presence of budding virus-like particles in human lymphoid cells used for HIV cultivation, p. 122. In: Vol. I, Abstracts VII International Conference on AIDS, Florence, Italy.
Brennan, J.K., Lichtman, M.A., Chamberlain, J.K. and Leblond, P. 1976. Isolation of variant lymphoma cells with reduced growth requirements for extracellular calcium and magnesium and enhanced oncogenicity. Blood 47: 447–459.
Garry, R.F., Fermin, C.D., Hart, D.J. et al. 1990. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250: 1127–1129.
Armstrong, J.A. and Home, R. 1984. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 11: 370–372.
Tenner-Racz, K., Racz, P., Bofill, M. et al. 1986. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am. J. Pathol. 123: 9–15.
Le Tourneau, A., Audouin, J., Diebold, J. et al. 1986. LAV-like viral particles in lymph node germinal centers in patients with the persistent lymphadenopathy syndrome and the acquired immunodeficiency syndrome-related complex. Hum. Pathol. 17: 1047–1053.
O'Hara, C.J., Groopmen, J.E. and Federman, M. 1988. The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related lymphadenopathy syndromes. Hum. Pathol. 19: 545.
Culliton, B.J. 1992. The mysterious virus called “isn't”. Nature 358: 619.
Chiodi, F., Albert, J., Olausson, E. et al. 1988. Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection. AIDS Res. Hum. Retroviruses 4: 351–358.
Salahuddin, S.Z., Groopman, J.E., Markham, P.D. et al. 1984. HTLV-III symptom-free seronegative persons. Lancet II: 1418–1420.
Boussin, F., Rey, E., Dormont, D. et al. 1988. Isolation of HIV in a seronegative demented patient without symptoms of immune deficiency. Cancer Detect. Prev. 12: 257–265.
Bayliss, G.J., Jesson, W.J., Evans, B.A. et al. 1989. Isolation of HIV-1 from small volumes of heparinized whole blood. AIDS 3: 45–49.
Fiore, J.R., Angarano, G., Fico, C. et al. 1990. Cell cultures from small amounts of heparinized whole blood enhance HIV-1 isolation rate. AIDS 4: 1295–1296.
Schüpbach, J., Jendis, J.B., Bron, C. et al. 1992. False-positive HIV-1 virus cultures using whole blood. AIDS 6: 1545–1546.
Hart, C., Spira, T., Moore, J. et al. 1988. Direct detection of HIV RNA expression in seropositive subjects. Lancet II: 596–599.
Aaronson, S.A., Todaro, G.J. and Scholnick, E.M. 1971. Induction of murine C-type viruses from clonal lines of virus-free BALB/3T3 cells. Science 174: 157–159.
Hirsch, M.S., Phillips, S.M., Solnik, C. et al. 1972. Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Nat. Acad. Sci. 69: 1069–1072.
Toyoshima, K. and Vogt, P.K. 1969. Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virol. 38: 414–426.
Nakamura, N., Sugino, H., Takahara, K. et al. 1991. Endogenous retroviral LTR DNA sequences as markers for individual human chromosomes. Cytogenet. Cell Genet. 57: 18–22.
Varmus, H. and Brown, P. 1989. Retroviruses, p. 53–108. In: Mobile DNA. D. E. Berg, M. M. Howe (Eds.). American Society for Microbiology. Washington, D. C.
Weiss, R.A., Friis, R.R., Katz, E. et al. 1971. Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. Virol. 46: 920–938.
Temin, H.M. 1974. On the origin of RNA tumor viruses. Harvey Lect 69: 173–197.
Wain-Hobson, S. and Myers, G. 1990. Too close for comfort. Nature 347: 18.
Genetics of RNA tumour viruses. 1973. p. 656–699. In: The molecular biology of tumour viruses. J. Tooze (Ed.). Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
Saag, M.S., Hahn, B.H., Gibbons, J. et al. 1988. Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 334: 440.
Marx, J.L. 1988. The AIDS virus can take on many guises. Science 241: 1039–1040.
von Briesen, H., Becker, W.B., Henco, K. et al. 1987. Isolation frequency and growth properties of HIV-variants:Multiple simultaneous variants in a patient demonstrated by molecular cloning. J. Med. Virol. 23: 51–66.
Bolton, V., Pedersen, N.C., Higgins, J. et al. 1987. Unique p24 epitope marker to identify multiple human immunodeficiency virus variants in blood from the same individuals. J. Clin. Microbiol. 25: 1411–1415.
Wain-Hobson, S. 1989. HIV genome variability in vivo. AIDS 3: S13–S18.
Innocenti, P., Ottmann, M., Morand, P. et al. 1992. HIV-1 blood monocytes: Frequency of detection of proviral DNA using PCR in comparison with the total CD4 count. AIDS Res. Hum. Retroviruses 8: 261–268.
Meyerhans, A., Cheynier, R., Albert, J. et al. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58: 901–910.
Robey, W.G., Nara, P.L., Poore, C.M. et al. 1987. Rapid assessment of relationships among HIV isolates by oligopeptide analyses of external envelope glycoproteins. AIDS Res. Hum. Retroviruses 3: 401–408.
Shaw, G.M., Hahn, B.H., Suresh, K.A. et al. 1984. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 226: 1165–1171.
Simmonds, P., Balfe, P., Peutherer, J.F. et al. 1990. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64: 864–872.
Van Voorhis, B.J., Martinez, A., Mayer, K. and Anderson, D.J. 1991. Detection of human immunodeficiency virus type 1 in semen from seropositive men using culture and polymerase chain reaction deoxyribonucleic acid amplification techniques. Fertil. Steril. 55: 588–594.
Deter, C., Agut, H. and Garbarg-Chenon, A. 1992. Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS 6: 659–663.
Becker, J.L., Kazan, U., Nugeyre, M.T. et al. 1986. Infection of insect lines by HIV, agent of AIDS, and evidence for HIV proviral DNA in insects from Central Africa. C. R. Acad. Sci. Paris. 300: 303–306.
Arya, S.K., Gallo, R.C., Hahn, B.H. et al. 1984. Homology of genome of AIDS-associated virus with genomes of human T-Cell leukemia viruses. Science 225: 927–930.
Mager, D.L. and Freeman, J.D. 1987. Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses. J. Virol. 61: 4060–4066.
Banki, K., Maceda, J., Hurley, E. et al. 1992. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1 encodes a 28-kDa protein:a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc. Natl. Acad. Sci. 89: 1939–1943.
Webster, A.D.B., Dalgleish, A.G., Beattie, R. et al. 1986. Isolation of retroviruses from two patients with “common variable” hypogammaglobulinaemia. Lancet I: 581–582.
Ciampolillo, A., Marini, V. and Buscema, M. 1989. Retrovirus-like sequences in Graves' disease: Implications for human autoimmunity. Lancet I: 1096–1100.
Horwitz, M.S., Boyce-Jacino, M.T. and Faras, A.J. 1992. Novel human endogenous sequences related to human immunodeficiency virus type 1. J. Virol. 66: 2170–2179.
Farzadegan, H., Polls, M., Wolinsky, S.M. et al. 1988. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual Men. Ann. Int. Med. 108: 785–790.
Horsburgh, C.R., Ou, C.Y., Holmberg, S.D. et al. 1989. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. NEJM 321: 1678–1680.
Mikovits, J.A., Lohrey, N., Schuloff, R., Ruscetti, F. 1991. Immune activation of latent HIV-1 expression in monocyte/macrophages, p. 151. In: Vol. I, Abstracts VII International Conference on AIDS, Florence, Italy.
Vartanian, J.P., Meyerhans, A., Henry, M. and Wain-Hobson, S. 1992. High-resolution structure of an HIV-1 quasispecies: Identification of novel coding sequences. AIDS 6: 1095–1098.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Papadopulos-Eleopulos, E., Turner, V. & Papadimitriou, J. Is a Positive Western Blot Proof of HIV Infection?. Nat Biotechnol 11, 696–707 (1993). https://doi.org/10.1038/nbt0693-696
Issue Date:
DOI: https://doi.org/10.1038/nbt0693-696
